Sustained virologic response to standard interferon or pegylated interferon and ribavirin in patients with hepatitis C virus genotype 5: systematic review and meta-analysis of ten studies and 423 patients

被引：0
|
作者：
Pardha Devaki
David Jencks
Brittany E. Yee
Mindie H. Nguyen
机构：
[1] Cleveland Clinic,Digestive Disease Institute
[2] Veterans’ Administration Health Care System,Department of Medicine
[3] University of California,School of Medicine
[4] Stanford University Medical Center,Division of Gastroenterology and Hepatology
来源：
Hepatology International | 2015年 / 9卷
关键词：
Hepatitis C; Genotype 5; Sustained virologic response; Peginterferon and ribavirin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：431 / 437
页数：6
相关论文
共 50 条
  • [41] Vitamin D and B12 Supplementation and Sustained Virologic Response in Chronic Hepatitis C Patients Treated With Pegylated Interferon and Ribavirin
    Mihai, Catalina
    Dranga, Mihaela
    Drug, Vasile
    Prelipcean, Cristina Cijevschi
    GASTROENTEROLOGY, 2014, 146 (05) : S982 - S982
  • [42] Is sustained virologic response durable in patients with chronic hepatitis C treated with interferon alfa with or without ribavirin?
    Cheinquer, N
    Cheinquer, H
    Coelho-Borges, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 103 - 103
  • [43] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    S. K. Tohra
    S. Taneja
    S. Ghosh
    B. K. Sharma
    A. Duseja
    R. K. Dhiman
    A. Das
    Y. K. Chawla
    Digestive Diseases and Sciences, 2011, 56
  • [44] Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C
    Tohra, S. K.
    Taneja, S.
    Ghosh, S.
    Sharma, B. K.
    Duseja, A.
    Dhiman, R. K.
    Das, A.
    Chawla, Y. K.
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2449 - 2455
  • [45] Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
    Xiaoyan Guo
    Zhixin Zhao
    Junqiang Xie
    Qingxian Cai
    Xiaohong Zhang
    Liang Peng
    Zhiliang Gao
    Virology Journal, 9
  • [46] Prediction of response to pegylated-interferon-α and ribavirin therapy in Chinese patients infected with different hepatitis C virus genotype
    Guo, Xiaoyan
    Zhao, Zhixin
    Xie, Junqiang
    Cai, Qingxian
    Zhang, Xiaohong
    Peng, Liang
    Gao, Zhiliang
    VIROLOGY JOURNAL, 2012, 9
  • [47] Insulin resistance, fibrosis and genotype are predictors of sustained response rate to pegylated interferon plus ribavirin in patients with chronic hepatitis C
    Romero-Gomez, M
    Viloria, MM
    Corpas, R
    Cruz, M
    Sanchez-Munoz, D
    Grande, L
    Castillo, J
    Suarez, E
    Camacho, I
    Nogales, MC
    JOURNAL OF HEPATOLOGY, 2004, 40 : 150 - 150
  • [48] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    HEPATITIS MONTHLY, 2013, 13 (12)
  • [49] TREATMENT EFFICACY OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN PATIENTS INFECTED WITH GENOTYPE 6 HEPATITIS C VIRUS
    Shin, S. R.
    Park, S. H.
    Lee, M. S.
    Lee, J. W.
    Lee, J. S.
    Kim, Y. S.
    Choi, M. S.
    Kim, S. M.
    Jeong, S. -H.
    Shon, J. H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S480 - S480
  • [50] HEPATITIS C VIRUS CORE GENE POLYMORPHISMS CORRELATE WITH LIVER FIBROSIS AND VIROLOGIC RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY IN PATIENTS WITH GENOTYPE 1 INFECTION
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Liu, Chen-Hua
    Liu, Chun-Jen
    Chen, Pei-Jer
    Kao, Jia-Horng
    HEPATOLOGY, 2010, 52 (04) : 761A - 761A
12345